Serum transthyretin (sTTR) is the precursor protein of wild type transthyretin amyloid cardiomyopathy (ATTRwt-CM) and the biological target of tafamidis. Its role as a prognostic marker in tafamidis-treated ATTRwt-CM is still debated.
Serum transthyretin (sTTR) is the precursor protein of wild type transthyretin amyloid cardiomyopathy (ATTRwt-CM) and the biological target of tafamidis. Its role as a prognostic marker in tafamidis-treated ATTRwt-CM is still debated.
Serum prealbumin and disease progression in patients with wild-type Transthyretin Cardiomyopathy on treatment with Tafamidis.
BALDAN, MARCO
2023/2024
Abstract
Serum transthyretin (sTTR) is the precursor protein of wild type transthyretin amyloid cardiomyopathy (ATTRwt-CM) and the biological target of tafamidis. Its role as a prognostic marker in tafamidis-treated ATTRwt-CM is still debated.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi Baldan Marco.pdf
Accesso riservato
Dimensione
875.99 kB
Formato
Adobe PDF
|
875.99 kB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/20.500.12608/97191